Chief Medical Officer 360º’s Post

Analysis of #oligos can be challenging. Don't miss this informative webinar on #LCMS analysis to learn how to improve quantitation efficiency and success. #Pharmaron

Adiso is keeping #patientsfirst by working to shape a brighter future free from the burden of inflammatory disease. Listen to our recent conversation with Rahul Chaturvedi of the Biotech2050 podcast. https://t.ly/lF_JG #Leadership #IBD #ulcerativecolitis

🎙️ Podcast Alert: Navigating IND Applications & Pre-IND Meetings: Key Considerations And Misconceptions Listen now: https://ow.ly/ITpu50Sm11S In this podcast, glean insights from an experienced regulatory leader at Allucent and an expert currently navigating the complexities of the pre-IND stage at Ridgeline Therapeutics. They dive into best practices for pre-IND meetings and IND applications, helping you develop strategies to succeed in this increasingly challenging environment. #INDApplications #PharmaPodcast #DrugDevelopment #BiotechTalk #ClinicalTrials #FDAGuidance #RegulatoryAffairs #HealthcareInnovation

🎙️ Podcast Alert: Navigating IND Applications & Pre-IND Meetings: Key Considerations And Misconceptions Listen now: https://ow.ly/1lb850SFXez In this podcast, glean insights from an experienced regulatory leader at Allucent and an expert currently navigating the complexities of the pre-IND stage at Ridgeline Therapeutics. They dive into best practices for pre-IND meetings and IND applications, helping you develop strategies to succeed in this increasingly challenging environment. #INDApplications #PharmaPodcast #DrugDevelopment #BiotechTalk #ClinicalTrials #FDAGuidance #RegulatoryAffairs #HealthcareInnovation

🎙️ Podcast Alert: Navigating IND Applications & Pre-IND Meetings: Key Considerations And Misconceptions Listen now: https://ow.ly/7wsG50SiuzB In this podcast, glean insights from an experienced regulatory leader at Allucent and an expert currently navigating the complexities of the pre-IND stage at Ridgeline Therapeutics. They dive into best practices for pre-IND meetings and IND applications, helping you develop strategies to succeed in this increasingly challenging environment. #INDApplications #PharmaPodcast #DrugDevelopment #BiotechTalk #ClinicalTrials #FDAGuidance #RegulatoryAffairs #HealthcareInnovation

LISTEN NOW: In this special episode of the Pharmacy Friends podcast, the CEOs of Prime Therapeutics, Mostafa Kamal, and Capital Rx, A. J. Loiacono, share the story behind the strategic alliance between their organizations and their vision to reimagine pharmacy. “We knew that platform modernization was going to be an important priority for us,” Kamal said. “And when we stacked the options, everything that’s available externally, internal build, it was a no brainer that the right partner for us was Capital Rx. When you think about the capabilities, the alignment around vision and mission and key principles, and it also helps that there’s a level of trust in our relationship as well.” Read more and listen to the full episode here: https://bit.ly/3TGWvPU

When Capital Rx's Co-Founder & CEO, A. J. Loiacono, and Prime Therapeutics' CEO, Mostafa Kamal, recorded a special episode of The Astonishing Healthcare #podcast to discuss our alliance, they explained the unique benefits and capabilities JUDI® brings to market, as well as what this portends for the future of #pharmacybenefits. Watch the full episode of the podcast here: https://okt.to/FDhUu4

🎙️ Podcast Alert: Navigating IND Applications & Pre-IND Meetings: Key Considerations And Misconceptions Listen now: https://ow.ly/L9Jp50SiuBf In this podcast, glean insights from an experienced regulatory leader at Allucent and an expert currently navigating the complexities of the pre-IND stage at Ridgeline Therapeutics. They dive into best practices for pre-IND meetings and IND applications, helping you develop strategies to succeed in this increasingly challenging environment. #INDApplications #PharmaPodcast #DrugDevelopment #BiotechTalk #ClinicalTrials #FDAGuidance #RegulatoryAffairs #HealthcareInnovation

🎙️ Grow by Experimenting with Cheri Ackerman, Co-founder & CEO of Concerto Biosciences on the Building Biotechs Podcast This week on the podcast, Cheri does us the honor of having a very real conversation about the learning curve she's experienced co-founding Concerto Biosciences. It was so refreshing. If you're growing a company, you'll relate to so much of what she has to say. Here's a peek at what we discussed: ▪️Building a resilient company culture in a remote/hybrid environment ▪️Navigating fundraising in a challenging economic landscape ▪️Implementing organizational changes through "experimentation" ▪️Expanding your professional network in the biotech industry ▪️Essential reading for biotech entrepreneurs Also, a big congratulations to the Concerto Biosciences! They recently received FDA investigational new drug clearance for clinical trials of a therapeutic to treat atopic dermatitis! #BuildingBiotechs #BiotechLeadership #BiotechStartup #Podcast

🎙️ Podcast Alert: Navigating IND Applications & Pre-IND Meetings: Key Considerations And Misconceptions Listen now: https://ow.ly/tsHx50SiuAj In this podcast, glean insights from an experienced regulatory leader at Allucent and an expert currently navigating the complexities of the pre-IND stage at Ridgeline Therapeutics. They dive into best practices for pre-IND meetings and IND applications, helping you develop strategies to succeed in this increasingly challenging environment. #INDApplications #PharmaPodcast #DrugDevelopment #BiotechTalk #ClinicalTrials #FDAGuidance #RegulatoryAffairs #HealthcareInnovation